A detailed history of Commonwealth Equity Services, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 76,576 shares of MRNA stock, worth $5.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,576
Previous 75,184 1.85%
Holding current value
$5.03 Million
Previous $8.01 Million 13.49%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$101.21 - $166.61 $140,884 - $231,921
1,392 Added 1.85%
76,576 $9.09 Million
Q1 2024

Apr 29, 2024

BUY
$85.37 - $115.44 $35,087 - $47,445
411 Added 0.55%
75,184 $8.01 Million
Q4 2023

Feb 06, 2024

SELL
$69.51 - $104.43 $558,095 - $838,468
-8,029 Reduced 9.7%
74,773 $7.44 Million
Q3 2023

Oct 23, 2023

SELL
$96.41 - $126.61 $231,576 - $304,117
-2,402 Reduced 2.82%
82,802 $8.55 Million
Q2 2023

Aug 10, 2023

SELL
$118.5 - $160.53 $526,021 - $712,592
-4,439 Reduced 4.95%
85,204 $10.4 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $437,367 - $635,192
3,224 Added 3.73%
89,643 $13.8 Million
Q4 2022

Feb 07, 2023

SELL
$118.38 - $210.04 $316,074 - $560,806
-2,670 Reduced 3.0%
86,419 $15.5 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $1.31 Million - $2.15 Million
-11,096 Reduced 11.08%
89,089 $10.5 Million
Q2 2022

Jul 19, 2022

BUY
$117.13 - $176.59 $1.14 Million - $1.72 Million
9,742 Added 10.77%
100,185 $14.3 Million
Q1 2022

May 04, 2022

SELL
$126.46 - $235.05 $1.09 Million - $2.02 Million
-8,612 Reduced 8.69%
90,443 $15.6 Million
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $1.14 Million - $1.87 Million
-5,063 Reduced 4.86%
99,055 $25.2 Million
Q3 2021

Oct 29, 2021

BUY
$221.9 - $484.47 $815,926 - $1.78 Million
3,677 Added 3.66%
104,118 $40.1 Million
Q2 2021

Aug 11, 2021

SELL
$129.91 - $234.98 $640,456 - $1.16 Million
-4,930 Reduced 4.68%
100,441 $23.6 Million
Q1 2021

May 04, 2021

BUY
$109.18 - $185.98 $51,751 - $88,154
474 Added 0.45%
105,371 $13.8 Million
Q4 2020

Feb 11, 2021

BUY
$65.74 - $169.86 $788,354 - $2.04 Million
11,992 Added 12.91%
104,897 $11 Million
Q3 2020

Nov 05, 2020

BUY
$54.34 - $94.85 $734,785 - $1.28 Million
13,522 Added 17.03%
92,905 $6.57 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $998,395 - $2.69 Million
33,650 Added 73.58%
79,383 $5.1 Million
Q1 2020

May 11, 2020

BUY
$17.78 - $31.58 $517,433 - $919,041
29,102 Added 174.99%
45,733 $1.37 Million
Q4 2019

Feb 05, 2020

BUY
$13.93 - $21.28 $29,280 - $44,730
2,102 Added 14.47%
16,631 $325,000
Q3 2019

Oct 30, 2019

SELL
$12.26 - $18.07 $10,322 - $15,214
-842 Reduced 5.48%
14,529 $231,000
Q2 2019

Jul 19, 2019

BUY
$13.7 - $28.34 $210,582 - $435,614
15,371 New
15,371 $225,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.